Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency

Stine Knudsen, Bo Biering‐Sørensen, Birgitte Rahbek Kornum, Eva Rosa Petersen, Jette D. Ibsen, Steen Gammeltoft, Emmanuel Mignot, Poul Jennum

Neurology · 2012 · 45 citations · 5 references

Concepts

Abstract

We previously suggested clinical effects of early IV immunoglobulin (IVIg) treatment in sporadic narcolepsy with cataplexy (NC).[1][1] Below we present the first post-H1N1 vaccination NC case treated with IVIg, treated 19 days after the clear and abrupt onset of the disease. This is a single

References

5